Hematology Analyzer Market lucrative opportunities by 2028 examined in new market research report

Press Release

Hematology is the part of medical sciences mainly related to the research, diagnosis, and treatment of blood-related disorders. Hematology analyzers are specific and electronic systems that count red cells, leucocytes, and platelets in the blood, and also determines the level of hemoglobin and hematocrit in blood. Hematology technology has gain pace in a relatively short duration of time. In the conventional system, the process of CBC (complete blood count) were performed manually by a specialist in front of a microscope. Hemoglobin can also be identified manually applying a cyanmethemoglobin method, which is a slow and time consuming process. The new and technologically advanced hematology analyzer is equipped with the latest technologies that it can treat up to hundreds of samples in an hour. Modular structures and improvements in automation indicates that the new systems can be built in such a way that it can serve numerous analyzers, slide strainers and archiving facilities.

Download sample copy of this report:

Automated Hematology Analyzer to drive the global market

The higher preference for automated hematology instruments, along with increasing technological advancements, and the combination of basic flow-cytometry techniques in automated hematology analyzers are some of the key constituents that are propelling the demand for hematology analyzer in the market. Besides, growing demand for highly efficient hematology analyzers, in addition with high-sensitivity point-of-care (POC) in the hematology testing is also improving the growth in demand of the global hematology analyzer market. However, strict and time-consuming regulative policies for hematology and laboratory instruments also impeded the market growth of Hematology Analyzer. Moreover, the higher cost of hematology analyzers and threats of newcomers and stiff competition among existing players are likely to hinder the growth of the global hematology analyzers market.  Furthermore, protection and quality of hematology analyzer are likely to be a hurdle for the growth of the global hematology analyzer market. Growing occurrences of business among hematology instruments providers and manufacturers are one of the recent trends in the global hematology analyzer.

North America to dominate the overall Hematology Analyzer Market

The global Hematology Analyzer market is segmented into seven regions: North America, Latin America, Europe, CIS & Russia, Japan, APEJ (the Asia Pacific excluding Japan) and MEA. Among the countries mentioned above, North America dominates the global hematology analyzer, followed by Europe. This is due to the increasing adoption of automated hematology instruments by diagnostics laboratories in these regions. APEJ is anticipated to witness a high growth in the global Hematology Analyzer market.  Also, increasing focus toward emerging markets, such as India and China, could also open up opportunities for new players in the global hematology analyzer.  Moreover, raising awareness about better healthcare and a large patient population base are also driving the growth of the hematology analyzer & reagent market in Asia. MEA is one of the key budding regions that will create exceptional opportunity in the global Hematology Analyzer market over the forecast period.

Hematology Analyzer Market- Key Segments

According to number of Parameters, the Hematology Analyzer can be segmented as

  • Up to 10 Parameters
  • 10-30 Parameters
  • Above 30 Parameters

According to End Use Industries, the Hematology Analyzer can be segmented as

  • Clinical Laboratories
  • Research Laboratories

Download table of contents with figures & tables:

Hematology Analyzer Market- Key Manufacturers

The major companies operating in this market are Sysmex Corporation, Abbott Laboratories, Fisher Scientific, Beckman Coulter, Inc., Balio Diagnostics,  Bio-Rad Laboratories, Inc., Hycel, Mindray Medical International Limited, Spinreact, Siemens Healthcare, HORIBA, Ltd.,  Dymind Biotech, and NIHON KOHDEN CORPORATION.